Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081665 | SCV000113596 | benign | not specified | 2012-10-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000514666 | SCV000209403 | likely benign | not provided | 2019-03-04 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000514666 | SCV000610194 | likely benign | not provided | 2017-03-20 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001079729 | SCV000833365 | likely benign | Mowat-Wilson syndrome | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001079729 | SCV002045672 | benign | Mowat-Wilson syndrome | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002444550 | SCV002734164 | likely benign | Inborn genetic diseases | 2017-03-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV001079729 | SCV002806109 | likely benign | Mowat-Wilson syndrome | 2022-04-04 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003974980 | SCV004792185 | likely benign | ZEB2-related condition | 2021-11-12 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |